share_log

Stephens & Co. Initiates Coverage On C4 Therapeutics With Equal-Weight Rating, Announces Price Target of $4

Benzinga ·  Nov 18 23:24  · Ratings

Stephens & Co. analyst Sudan Loganathan initiates coverage on C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight rating and announces Price Target of $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment